ABOUT 55,000 new prostate cancer cases are recorded every year in the UK. Bladder cancer is less common, with around 10,500 ...

AstraZeneca's treatment for adults with muscle-invasive bladder cancer was approved in the U.S.

AstraZeneca has secured another expansion of its Imfinzi for use in cancer patients before and after surgery. | Imfinzi is ...

Learn the 7 vital bladder cancer warning signs that require immediate medical attention, including subtle early symptoms many ...

The FDA has approved Imfinzi® (durvalumab), in combination with gemcitabine and cisplatin, for the treatment of adult patients with MIBC.

She wears the color blue because it’s associated with colon cancer awareness. Courtesy Bryce Ramsey Friends and family were stunned when Ramsey learned in 2019 that she had Stage 3 colon cancer ...

The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in ...

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder ...

A urinary DNA methylation test showed potential for detecting high-grade or invasive bladder cancer, according to results of ...

Durability Results from BOND-003 data will be presented as a late breaker as part of AUA’s Practice-changing, Paradigm-shifting Clinical Trials ...

Aura Biosciences (AURA) has reported its Q4 and full-year 2024 financial results, prompting an ongoing decline in shares ...